GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » Gross-Profit-to-Asset %

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Gross-Profit-to-Asset % : 8.55% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Zhejiang Shengda Bio-Pharm Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥148.5 Mil. Zhejiang Shengda Bio-Pharm Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥1,737.2 Mil. Therefore, Zhejiang Shengda Bio-Pharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 8.55%.


Zhejiang Shengda Bio-Pharm Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co Gross-Profit-to-Asset % Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.82 29.27 13.18 7.65 6.90

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.76 7.66 7.75 4.89 8.55

Competitive Comparison of Zhejiang Shengda Bio-Pharm Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shengda Bio-Pharm Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Shengda Bio-Pharm Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shengda Bio-Pharm Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Zhejiang Shengda Bio-Pharm Co's Gross-Profit-to-Asset % falls into.



Zhejiang Shengda Bio-Pharm Co Gross-Profit-to-Asset % Calculation

Zhejiang Shengda Bio-Pharm Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=116.455/( (1655.208+1719.186)/ 2 )
=116.455/1687.197
=6.90 %

Zhejiang Shengda Bio-Pharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=148.468/( (1719.186+1755.191)/ 2 )
=148.468/1737.1885
=8.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Zhejiang Shengda Bio-Pharm Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Business Description

Traded in Other Exchanges
N/A
Address
No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.
Executives
Pang Ai Ming Director
Zhu Yong Gang Director

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Headlines

No Headlines